US2015057430A1PendingUtilityA1

Compound, use and method

Assignee: MEDICAL RES COUNCILPriority: Oct 8, 2007Filed: Aug 26, 2014Published: Feb 26, 2015
Est. expiryOct 8, 2027(~1.2 yrs left)· nominal 20-yr term from priority
A61P 5/24A61P 5/00A61P 43/00A61P 37/02A61P 35/00A61P 5/10A61P 9/00A61P 9/12A61P 5/02A61P 5/06A61P 39/00A61P 25/00A61P 13/08C07K 7/08A61K 38/1709A61P 1/18C07K 7/06G01N 2500/04A61P 17/02A61P 15/00A61P 15/08
42
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the use of an antagonist of kisspeptin in the manufacture of a medicament for the treatment of a condition induced and/or worsened by kisspeptin activity in an individual. The invention also provides certain defined peptide molecules, which may act as an antagonist of kisspeptin, which are of use in treating a condition induced and/or worsened by kisspeptin activity in an individual. In addition, the invention provides methods of identifying and/or using antagonists of kisspeptin and/or the defined peptides, and pharmaceutical compositions thereof.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . Use of an antagonist of kisspeptin in the manufacture of a medicament for the treatment of a condition induced and/or worsened by kisspeptin activity in an individual.

Join the waitlist — get patent alerts

Track US2015057430A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.